$IDRA
Idera Pharmaceuticals, Inc.
PRICE
$0.525 ▲8.583%
Last Close
VOLUME
1,078,481
DAY RANGE
0.44 - 0.52
52 WEEK
0.295 - 1.71
Key Metrics
Market Cap
25.61 M
Beta
0.91
Avg. Volume
2.52 M
Shares Outstanding
52.97 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-08
Next Dividend Date
Company Information
Harnessing the approach of the earliest researchers in immunotherapy and the company's vast experience in developing proprietary immunology platforms, Idera's development program is focused on priming the immune system to play a more powerful role in fighting cancer, ultimately increasing the number of people who can benefit from immunotherapy. Idera also continues to focus on the acquisition, development, and ultimate commercialization of drug candidates for both oncology and rare disease indications characterized by small, well-defined patient populations with serious unmet needs.
CEO: Vincent Milano
Website: www.iderapharma.com
HQ: 505 Eagleview Blvd Ste 212 Exton, 19341-1199 Pennsylvania
Related News